The ApoB/ApoA1 ratio divides the number of atherogenic particles by the number of protective ones. The giant AMORIS study showed it predicts fatal heart attack better than any conventional cholesterol fraction.
Standard range versus optimal range
| Framework | ApoB/ApoA1 value | Source |
|---|---|---|
| Lower risk, women | below 0.6 | AMORIS, Lancet 2001 |
| Lower risk, men | below 0.7 | AMORIS, Lancet 2001 |
| Higher risk | above 0.8-0.9 | AMORIS, Lancet 2001 |
When it runs high
A high ratio means many atherogenic particles relative to protective ones, the core imbalance behind plaque formation. It stays informative when cholesterol looks normal, which is exactly the situation where hidden risk lives.
- High ApoB from insulin resistance or familial lipid disorders
- Low ApoA1 from smoking, inactivity or inflammation
- Untreated dyslipidemia
- Diabetes and metabolic syndrome
When it runs low
A low ratio reflects few atherogenic particles and plenty of protective ones, the lipid pattern that keeps arteries clean into old age.
- Genetically favorable lipids
- Regular activity, healthy weight and non-smoking
- Effective lipid treatment
The ratio that outscored cholesterol
In 2001 the AMORIS study followed 175,000 Swedes and delivered a clean verdict, ApoB and the ApoB/ApoA1 ratio predicted fatal myocardial infarction better than LDL cholesterol, total cholesterol or any of the classic fractions. The logic is structural, every plaque-forming particle, LDL, VLDL, IDL, Lp(a), carries exactly one ApoB molecule, while ApoA1 tags the HDL side. The ratio is therefore a headcount of attackers versus defenders, not an estimate of cargo.
Why it needs no fasting
Cholesterol content per particle swings with meals and triglycerides, but particle counts do not. ApoB and ApoA1 can be measured accurately on a non-fasting sample, a practical advantage that removes the last excuse for skipping the test. In people with diabetes, obesity or high triglycerides, where calculated LDL routinely underestimates risk, the ratio exposes the excess particle burden that standard panels miss.
Where it fits in practice
European guidelines already recommend ApoB for risk refinement, and the ratio adds the protective side of the ledger for free once both are measured. It shines in three situations, borderline cases where the statin decision is unclear, metabolic syndrome where LDL misleads, and treated patients checking whether particle numbers truly fell. A falling ratio on treatment is among the most satisfying numbers in lipidology.
Related calculators
Related biomarkers ApoB · ApoA1 · TG/HDL ratio